NCT02236975View on ClinicalTrials.gov

First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

March 31, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

BuMA Supreme Biodegradable drug coating coronary stent system

DEVICE

Resolute Integrity durable polymer stent system

Trial Locations (12)

Unknown

Imelda Hospital, Bonheiden

CHU Chaleroi, Chaleroi

Oost-limburg Hospital, Genk

AMC, Amsterdam

OLVG, Amsterdam

UMCG, Groningen

Maasstad Hospital, Rotterdam

Hospita; Garcia de Orta, Almada

Santa Maria University Hospital, Lisbon

Gaia/Espinho Hospital Centers, Porto

University Hospital Madrid, Madrid

Hospital Álvaro Cunqueiro, Vigo

All Listed Sponsors
lead

Sino Medical Sciences Technology Inc.

INDUSTRY

NCT02236975 - First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis | Biotech Hunter | Biotech Hunter